Presentation is loading. Please wait.

Presentation is loading. Please wait.

Rubella Surveillance and Control in Low-Resource Settings: Limitations, Biases, and Potential for Strengthening Amy Winter, PhD Candidate, Princeton University.

Similar presentations


Presentation on theme: "Rubella Surveillance and Control in Low-Resource Settings: Limitations, Biases, and Potential for Strengthening Amy Winter, PhD Candidate, Princeton University."— Presentation transcript:

1 Rubella Surveillance and Control in Low-Resource Settings: Limitations, Biases, and Potential for Strengthening Amy Winter, PhD Candidate, Princeton University Advisor: Jess Metcalf Assistant Professor of Ecology and Evolutionary Biology, Princeton University Funding Sources:

2 Rubella Surveillance and Control in Information Scarce Settings: Limitations, Biases, and Potential for Strengthening Amy Winter, PhD Candidate, Princeton University Funding Sources: Advisor: Jess Metcalf Assistant Professor of Ecology and Evolutionary Biology, Princeton University

3 Rubella & Congenital Rubella Syndrome (CRS) From just before conception and during the first 16 weeks of gestation, rubella infection may cause CRS in up to 65% of cases, or may result in spontaneous abortion or stillbirth 1 Generally mild infection among children IntroductionOverviewEndemic settingsControl SettingsConclusions

4 Rubella Containing Vaccine (RCV) A safe, effective, and inexpensive rubella vaccine exists Fairly easy and cheap public health intervention – the rubella vaccine can be easily combined with the measles vaccine – additional 0.30 USD per vaccine dose IntroductionOverviewEndemic settingsControl SettingsConclusions

5 Data source: WHO/IVB Database, as of 29 September 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization (141 countries or 72.7%) (18 countries or 9.3%) (35 countries or 18%) Introduced to date Planned introductions in 2015-2016 Not Available, Not Introduced/No Plans Not applicable Current and Future Use of Rubella-Containing Vaccine IntroductionOverviewEndemic settingsControl SettingsConclusions

6 IntroductionObjectivesMethodsResultsLimitations & Conclusions GAVI is providing support for a one time catch-up campaign with the measles-rubella (MR) vaccine Rubella Vaccine Support

7 ? Global Incidence of Rubella and CRS CDC (2015). "Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination — 2000–2014." MMWR 64(37): 1052-1055. IntroductionOverviewEndemic settingsControl SettingsConclusions

8 ? Global Incidence of Rubella and CRS IntroductionOverviewEndemic settingsControl SettingsConclusions

9 ? Global Incidence of Rubella and CRS IntroductionOverviewEndemic settingsControl SettingsConclusions

10 Surveillance Issues for Rubella and CRS Rubella -Epidemiological: up to 50% of infections are asymptomatic -Structural: impediments in presenting for care, recognition and collection of samples by healthcare worker, reporting or sending samples CRS (in addition to above) -Epidemiological: can result in fetal death, miscarriage, or stillbirth, birth defects low specificity of detecting CRS IntroductionOverviewEndemic settingsControl SettingsConclusions (many the same for measles)

11 Rubella Surveillance and Control in Information Scarce Settings 1.Endemic rubella settings: Countries where RCV has not been introduced where rubella is endemic 1.Rubella control settings: Countries where RCV has recently been introduced Two Types of Rubella Settings IntroductionOverviewEndemic settingsControl SettingsConclusions

12 1.Endemic rubella settings: Countries where RCV has not been introduced where rubella is endemic What is the current burden of CRS? What will be the effect of RCV introduction on CRS incidence? 1.Rubella control settings: Countries where RCV has recently been introduced What is the effect of rubella vaccine introduction on CRS incidence? Rubella Surveillance and Control in Information Scarce Settings Two Types of Rubella Settings IntroductionOverviewEndemic settingsControl SettingsConclusions

13 1.Endemic rubella settings: Countries where RCV has not been introduced where rubella is endemic What is the current burden of CRS? What will be the effect of RCV introduction on CRS incidence? 1.Rubella control settings: Countries where RCV has recently been introduced What is the effect of rubella vaccine introduction on CRS incidence? Rubella Surveillance and Control in Information Scarce Settings Two Types of Rubella Settings IntroductionOverviewEndemic settingsControl SettingsConclusions RUBELLA CONTROL WILL BE DRIVEN BY MEASLES CONTROL

14 1.Endemic rubella settings: Countries where RCV has not been introduced where rubella is endemic What is the current burden of CRS? What will be the effect of RCV introduction on CRS incidence? 1.Rubella control settings: Countries where RCV has recently been introduced What is the effect of rubella vaccine introduction on CRS incidence? Rubella Surveillance and Control in Information Scarce Settings Two Types of Rubella Settings IntroductionOverviewEndemic settingsControl SettingsConclusions

15 S&C in Rubella Endemic Countries What is the current burden of CRS? Key Unknowns to Clarify Existing Data Sources Modeling to Fill Knowledge Gaps, and Address Core Considerations Current rubella epidemiology - Current burden of CRS - CRS incidence surveillance data - CRS prevalence estimates - Rubella age-specific IgG serology to reveal population immunity Extrapolation from age serology to infer CRS burden IntroductionOverviewEndemic settingsControl SettingsConclusions

16 S&C in Rubella Endemic Countries What is the current burden of CRS? IntroductionOverviewEndemic settingsControl SettingsConclusions Key Unknowns to Clarify Existing Data Sources Modeling to Fill Knowledge Gaps, and Address Core Considerations Current rubella epidemiology - Current burden of CRS - CRS incidence surveillance data - CRS prevalence estimates - Rubella age-specific IgG serology to reveal population immunity Extrapolation from age serology to infer CRS burden

17 S&C in Rubella Endemic Countries What is the current burden of CRS? IntroductionOverviewEndemic settingsControl SettingsConclusions Key Unknowns to Clarify Existing Data Sources Modeling to Fill Knowledge Gaps, and Address Core Considerations Current rubella epidemiology - Current burden of CRS - CRS incidence surveillance data - CRS prevalence estimates - Rubella age-specific IgG serology to reveal population immunity Extrapolation from age serology to infer CRS burden

18 ? Estimated median numbers of CRS cases born by country in 2010 105,000 CRS cases globally (range: 54,000-180,000) S&C in Rubella Endemic Countries What is the current burden of CRS? IntroductionOverviewEndemic settingsControl SettingsConclusions

19 What is the current burden of CRS? S&C in Rubella Endemic Countries IntroductionOverviewEndemic settingsControl SettingsConclusions Rely on age-specific IgG serology few age groups non population based samples Estimate annual average force of infection for < 13 years old and ≥ 13 years old using catalytic model then estimate CRS incidence from force of infection overestimate CRS burden

20 What is the current burden of CRS? S&C in Rubella Endemic Countries IntroductionOverviewEndemic settingsControl SettingsConclusions Rely on age-specific IgG serology few age groups non population based samples Estimate annual average force of infection for < 13 years old and ≥ 13 years old using catalytic model then estimate CRS incidence from force of infection overestimate CRS burden A Proportion seropositive

21 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries IntroductionOverviewEndemic settingsControl SettingsConclusions a.Will introducing RCV increase the burden of CRS? b.Are there locations at highest risk of CRS increases? c.Will introducing RCV result in rubella elimination?

22 Current rubella epidemiology - Transmission parameters (R0, seasonal changes) - Contact pattern over age - Country demography - Rubella age incidence data - fever-rash surveillance - rubella IgM serology - Rubella IgG serology - Contact diaries - National census, surveys - Analytic results for R0 - TSIR for seasonality - Age structured model predictions for CRS burden following vaccinations RCV Coverage Predictions - Measles vaccination coverage - MOH administrative measles vaccination coverage, or survey data Spatial variability - in rubella dynamics - in vaccine access - in demography - Spatial connectivity - Spatially indexed fever-rash surveillance - Spatially indexed IgM or IgG serology - Spatially refined data on vaccine coverage - Subnational demographic data (www.worldpop.org.uk) - Geospatial mobility data - Meta-population models to predict extinction probability - Age-structured meta- population models to predict CRS burden following vaccination - Estimating travel from spatial interaction models Key Unknowns to ClarifyExisting Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries IntroductionOverviewEndemic settingsControl SettingsConclusions a.Will introducing RCV increase the burden of CRS? b.Are there locations at highest risk of CRS increases? c.Will introducing RCV result in rubella elimination? Patching existing data sources with mathematical modeling can explore effects of RCV introduction

23 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries a. Will introducing RCV increase the burden of CRS? Inadequate routine vaccination coverage potentially increase CRS Burden! fertility average ages of infection Rubella childhood vaccination paradox: IntroductionOverviewEndemic settingsControl SettingsConclusions

24 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries a. Will introducing RCV increase the burden of CRS? IntroductionOverviewEndemic settingsControl SettingsConclusions Current rubella epidemiology - Transmission parameters (R0, seasonal changes) - Contact pattern over age - Country demography - Rubella age incidence data - fever-rash surveillance - rubella IgM serology - Rubella IgG serology - Contact diaries - National census, surveys - Analytic results for R0 - TSIR for seasonality - Age structured model predictions for CRS burden following vaccinations RCV Coverage Predictions - Measles vaccination coverage - MOH administrative measles vaccination coverage, or survey data Key Unknowns to ClarifyExisting Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration

25 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries a. Will introducing RCV increase the burden of CRS? IntroductionOverviewEndemic settingsControl SettingsConclusions Current rubella epidemiology - Transmission parameters (R0, seasonal changes) - Contact pattern over age - Country demography - Rubella age incidence data - fever-rash surveillance - rubella IgM serology - Rubella IgG serology - Contact diaries - National census, surveys - Analytic results for R0 - TSIR for seasonality - Age structured model predictions for CRS burden following vaccinations RCV Coverage Predictions - Measles vaccination coverage - MOH administrative measles vaccination coverage, or survey data Key Unknowns to ClarifyExisting Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration

26 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries a. Will introducing RCV increase the burden of CRS? R 0 ranges 2 to 5 IntroductionOverviewEndemic settingsControl SettingsConclusions Current rubella epidemiology - Transmission parameters (R0, seasonal changes) - Contact pattern over age - Country demography - Rubella age incidence data - fever-rash surveillance - rubella IgM serology - Rubella IgG serology - Contact diaries - National census, surveys - Analytic results for R0 - TSIR for seasonality - Age structured model predictions for CRS burden following vaccinations RCV Coverage Predictions - Measles vaccination coverage - MOH administrative measles vaccination coverage, or survey data Key Unknowns to ClarifyExisting Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration

27 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries a. Will introducing RCV increase the burden of CRS? D E FG R 0 ranges 2 to 5 IntroductionOverviewEndemic settingsControl SettingsConclusions Current rubella epidemiology - Transmission parameters (R0, seasonal changes) - Contact pattern over age - Country demography - Rubella age incidence data - fever-rash surveillance - rubella IgM serology - Rubella IgG serology - Contact diaries - National census, surveys - Analytic results for R0 - TSIR for seasonality - Age structured model predictions for CRS burden following vaccinations RCV Coverage Predictions - Measles vaccination coverage - MOH administrative measles vaccination coverage, or survey data Key Unknowns to ClarifyExisting Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration routine only routine + catch-up

28 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries b. Are there locations where the burden of CRS will increase following RCV introduction? c. Will introducing RCV result in rubella elimination? IntroductionOverviewEndemic settingsControl SettingsConclusions Current rubella epidemiology … …. ………… RCV Coverage Predictions…… Key Unknowns to Clarify Existing Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration Spatial variability - in rubella dynamics - in vaccine access - in demography - Spatial connectivity - Spatially indexed fever- rash surveillance - Spatially indexed IgM or IgG serology - Spatially refined data on vaccine coverage - Subnational demographic data (worldpop.org.uk) - Geospatial mobility data - Meta-population models to predict extinction probability - Age-structured meta- population models to predict CRS burden following vaccination - Estimating travel from spatial interaction models

29 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries b. Are there locations where the burden of CRS will increase following RCV introduction? c. Will introducing RCV result in rubella elimination? Connectivity IntroductionOverviewEndemic settingsControl SettingsConclusions Current rubella epidemiology … …. ………… RCV Coverage Predictions…… Key Unknowns to Clarify Existing Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration Spatial variability - in rubella dynamics - in vaccine access - in demography - Spatial connectivity - Spatially indexed fever- rash surveillance - Spatially indexed IgM or IgG serology - Spatially refined data on vaccine coverage - Subnational demographic data (worldpop.org.uk) - Geospatial mobility data - Meta-population models to predict extinction probability - Age-structured meta- population models to predict CRS burden following vaccination - Estimating travel from spatial interaction models A

30 What will be the effect of RCV introduction on CRS incidence? S&C in Rubella Endemic Countries b. Are there locations where the burden of CRS will increase following RCV introduction? c. Will introducing RCV result in rubella elimination? Connectivity IntroductionOverviewEndemic settingsControl SettingsConclusions Current rubella epidemiology … …. ………… RCV Coverage Predictions…… Key Unknowns to Clarify Existing Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration Spatial variability - in rubella dynamics - in vaccine access - in demography - Spatial connectivity - Spatially indexed fever- rash surveillance - Spatially indexed IgM or IgG serology - Spatially refined data on vaccine coverage - Subnational demographic data (worldpop.org.uk) - Geospatial mobility data - Meta-population models to predict extinction probability - Age-structured meta- population models to predict CRS burden following vaccination - Estimating travel from spatial interaction models A BC

31 1.Endemic rubella settings: Countries where RCV has not been introduced where rubella is endemic What is the current burden of CRS? What will be the effect of RCV introduction on CRS incidence? 1.Rubella control settings: Countries where RCV has recently been introduced What is the effect of rubella vaccine introduction on CRS incidence? Rubella Surveillance and Control in Information Scare Settings Two Types of Rubella Settings IntroductionOverviewEndemic settingsControl SettingsConclusions

32 What is the effect of RCV introduction on CRS incidence? S&C in Rubella Control Countries IntroductionOverviewEndemic settingsControl SettingsConclusions Post vaccine unknowns - RCV coverage - Population immunity profile - MOH administrative RCV coverage, or survey data - Pre and post rubella serological surveys of vaccination age children - Rubella IgG age-specific serological survey - Subnational susceptibility mapping - Age structured meta- population models to predict CRS burden Key Unknowns to ClarifyExisting Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration Current rubella epidemiology ………… ………… Spatial variability … ………… …………

33 What is the effect of RCV introduction on CRS incidence? S&C in Rubella Control Countries IntroductionOverviewEndemic settingsControl SettingsConclusions Post vaccine unknowns - RCV coverage - Population immunity profile - MOH administrative RCV coverage, or survey data - Pre and post rubella serological surveys of vaccination age children - Rubella IgG age-specific serological survey - Subnational susceptibility mapping - Age structured meta- population models to predict CRS burden Key Unknowns to ClarifyExisting Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration Current rubella epidemiology ………… ………… Spatial variability … ………… …………

34 What is the effect of RCV introduction on CRS incidence? S&C in Rubella Control Countries IntroductionOverviewEndemic settingsControl SettingsConclusions nested within existing surveillance system Post vaccine unknowns - RCV coverage - Population immunity profile - MOH administrative RCV coverage, or survey data - Pre and post rubella serological surveys of vaccination age children - Rubella IgG age-specific serological survey - Subnational susceptibility mapping - Age structured meta- population models to predict CRS burden Key Unknowns to ClarifyExisting Data Sources Modeling to Fill Knowledge Gaps, and Address Core Consideration Current rubella epidemiology ………… ………… Spatial variability … ………… …………

35 What is the effect of RCV introduction on CRS incidence? S&C in Rubella Control Countries IgG serology data nested within measles/rubella surveillance system IntroductionOverviewEndemic settingsControl SettingsConclusions A

36 What is the effect of RCV introduction on CRS incidence? S&C in Rubella Control Countries IgG serology data nested within measles/rubella surveillance system Non-probability sample IntroductionOverviewEndemic settingsControl SettingsConclusions A B 2010: 320 samples2011: 479 samples2012: 497 samples2013: 600 samples2014: 616 samples

37 What is the effect of RCV introduction on CRS incidence? S&C in Rubella Control Countries IgG serology data nested within measles/rubella surveillance system Non-probability sample IntroductionOverviewEndemic settingsControl SettingsConclusions A B C 2010: 320 samples2011: 479 samples2012: 497 samples2013: 600 samples2014: 616 samples

38 IntroductionOverviewEndemic settingsControl SettingsConclusions Mathematical modeling can be used in scarce-information settings to estimate the burden of CRS and inform future vaccination policy Population-based age-structured serological data is powerful reduce CRS estimation bias inform unknown epidemiological parameters determine population immunity levels in honeymoon period  Inform future rubella control vaccination policies Rubella control will be driven by measles control

39 Thanks for listening! Funding Sources: Amy Winter awinter@princeton.edu Jess Metcalf cmetcalf@princeton.edu


Download ppt "Rubella Surveillance and Control in Low-Resource Settings: Limitations, Biases, and Potential for Strengthening Amy Winter, PhD Candidate, Princeton University."

Similar presentations


Ads by Google